Biostrap exits consumer market with new health monitoring wearable

Company targets enterprise and research customers with Kairos wearable device.

Precision health monitoring company Biostrap has unveiled its latest wearable device, Kairos. The company says Kairos “revolutionizes” data visualization of the autonomic nervous system, providing a unique measurement of the sympathetic and parasympathetic branches from a wrist-worn device.

Known for its biosensor-based health monitoring solutions, Biostrap’s devices capture clinical-grade, continuous, high-fidelity raw data for health and well-being analysis. The launch of Kairos heralds Biostrap’s transition from the consumer wearable market to providing configurable hardware and software for enterprise and research purposes.

A key feature of Kairos is its comprehensive stress resilience measurement. Users can now understand their fight-or-flight response and rest-and-digest mode during rest periods, throughout the day and in real-time. The device, wearable on the wrist, forearm, or bicep, uses a high-sensitivity CMOS optical sensor to capture raw PPG data. This allows for more accurate computation of biometrics such as active and resting heart rate, HRV, beat-to-beat intervals, respiratory rate and sleep-related parameters.

Detailed nervous system analysis

Biostrap provides clinically reliable nervous system analysis through detailed and transparent biometric measurements, including the new Spot Check feature. By offering real-time visualization of the underlying PPG signal, signal quality and R-R intervals, Biostrap provides access to every data point captured via the Vital Science app, Remote Monitoring dashboard, APIs or SDKs.

“We are thrilled to launch Kairos and our new Spot Check feature,” said Sameer Sontakey, CEO of Biostrap. “Our dedicated team has worked tirelessly to create this cutting-edge culmination of hardware and software that positions Biostrap as the leader in quantifying clinical-grade heart rate variability parameters and providing researchers and healthtech visionaries invaluable insights into their patients’ and clients’ autonomic nervous system like never before.”

The company also says that Kairos boasts four times better battery life and ten times faster syncing speeds compared to previous Biostrap devices.

Biostrap has already attracted the attention of the UK’s National Police Wellbeing Service (NPWS), which aims to improve the health and safety of police officers.

“The differentiator with Biostrap is the company’s willingness to adapt how it presents data and information to users based on their experiences and our priority issue which is sleep, fatigue and recovery,” said Andy Rhodes, director at NPWS. “We wanted an end-to-end solution which is tuned into the reality of emergency responder work, and Biostrap has listened to frontline officers to achieve that. The accuracy of Biostrap means we can rely on the key data points and present them to officers with a high degree of confidence. It’s why we are confident that our sleep, fatigue and recovery programme has been developed by policing for policing.”